Economic Evaluation of Contact Force Catheter Ablation for Persistent Atrial Fibrillation in the United States.

ABSTRACT:

Background

Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia, and it increases the risk of stroke, heart failure, and other cardiac complications. Catheter ablation is well-established as a treatment for paroxysmal AF, and the recent PRECEPT (Prospective Review of the Safety and Effectiveness of the THERMOCOOL SMARTTOUCH SF Catheter Evaluated for Treating Symptomatic Persistent AF) clinical trial resulted in the catheter gaining approval for the treatment of persistent AF in the United States.

Objectives

To construct an economic simulation model, based on the results of the PRECEPT trial, to monetize the impact of radiofrequency catheter ablation (RFCA) compared with medical therapy (MT).

Methods

Cost-offset and break-even analyses were performed to as

SUBMITTER: Osorio J 

PROVIDER: S-EPMC9795304 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature